ArticleOrphanet journal of rare diseases2017

Health technology assessment of new drugs for rare disorders in Canada: impact of disease prevalence and cost.

Nigel S B RawsonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.